|
|
|
|
| LEADER |
00741nam 2200325#c 4500 |
| 001 |
UMA-2161 |
| 003 |
UMA |
| 005 |
20230415 193418 |
| 008 |
230415suuuu####sp#a#########||||#0#spa#d |
| 336 |
|
|
|a texto
|
| 337 |
|
|
|a no mediado
|
| 338 |
|
|
|a volumen
|
| 901 |
|
|
|a 7178
|
| 020 |
|
|
|a 8481744972
|
| 080 |
|
|
|a 616.079
|
| 092 |
|
|
|a 616.079
|
| 245 |
|
|
|a Inmunología
|
| 100 |
|
|
|a Roitt
|b Ivan
|
| 100 |
|
|
|a Brostoff
|b Jonathan
|
| 100 |
|
|
|a Male
|b David
|
| 650 |
|
|
|a Inmunoterapia
|
| 650 |
|
|
|a Inmunología
|
| 650 |
|
|
|a Inmunología humana
|
| 650 |
|
|
|a Enfermedades autoimunitarias
|
| 650 |
|
|
|a Inmunodeficiencia
|
| 041 |
|
|
|a spa
|
| 044 |
|
|
|a sp#
|
| 300 |
|
|
|a 423 p. : il.
|
| 260 |
|
|
|a Madrid
|b Harcourt
|c 2000
|
| 250 |
|
|
|a 5. ed.
|